T cells play a big role in bringing cell and gene therapies to patients. Despite this clinical potential, scientists developing T cell therapies such as chimeric antigen receptor (CAR)-T cells, ...

Improving the therapeutic quality and consistency of cell and gene therapies requires the adoption of enhanced Critical Quality Attributes (CQAs) throughout the development and manufacturing processes ...

Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

To permanently access this App Note for free, fill out the short form below. CAR-T cell therapy research for B cell cancers must meet FDA guidelines for safety, efficacy, and stability. Accurate ...

Like traditional biologics, cell and gene therapies (CGTs) must meet safety and efficacy standards before they can be administered to human patients. But the manufacturing processes used for this new ...

The emergence of advanced therapy medicinal products (ATMPs) including cell therapies, has led to many bioanalytical laboratories implementing qPCR and/or newer technologies like digital PCR for ...

VENLO, the Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR ...

Cellares announced multiple strategic technology partners Sept. 17 to advance its Cell Q. NJBIZ has reported extensively on the cell therapy manufacturer, which operates a Smart Factory in Bridgewater ...

TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) ...

Techne, bioMerieux, Roche, Lonza Group, Miltenyi Biotec India and More Cell and Gene Therapy Manufacturing QC Market Cell and ...